Negative allosteric regulation of protein arginine methyltransferase 1 (PRMT1) through half-of-sites reactivity
Vincent Z. Rossi, Robert S. Wilson-Kovacs, Yuan Gao, Caroline Velez, Sofiia Hakh, Chao Xue, Jun Qu, Vicki Wysocki, Orlando Acevedo, Joan M. Hevel · 2026
Read Negative allosteric regulation of protein arginine methyltransferase 1 (PRMT1) through half-of-sites reactivity by Vincent Z. Rossi, Robert S. Wilson-Kovacs, Yuan Gao, Caroline Velez, Sofiia Hakh, Chao Xue, Jun Qu, Vicki Wysocki, Orlando Acevedo, Joan M. Hevel (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13571421.txt.
Description
Protein arginine methyltransferase 1 (PRMT1) activity is essential for maintaining proper eukaryotic cellular function; however, its dysregulation contributes to the progression of several human diseases and cancers, making PRMT1 an attractive therapeutic target. Efforts to inhibit PRMT1 through active-site-directed competitive strategies have faced significant challenges, highlighting the need to discover and exploit allosteric regulatory mechanisms.
Catalog record
| CREATOR | Vincent Z. Rossi, Robert S. Wilson-Kovacs, Yuan Gao, Caroline Velez, Sofiia Hakh, Chao Xue, Jun Qu, Vicki Wysocki, Orlando Acevedo, Joan M. Hevel |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |